# MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

> **NCT07182864** · PHASE1,PHASE2 · COMPLETED · sponsor: **Minghui Pharmaceutical (Hangzhou) Ltd** · enrollment: 160 (actual)

## Conditions studied

- Atopic Dermatitis (AD)

## Interventions

- **DRUG:** MH004 0.1% Ointment
- **DRUG:** MH004 0.3% Ointment
- **DRUG:** MH004 1.0% Ointment
- **DRUG:** MH004 3.0% Ointment
- **DRUG:** Vehicle Ointment

## Key facts

- **NCT ID:** NCT07182864
- **Lead sponsor:** Minghui Pharmaceutical (Hangzhou) Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-06
- **Primary completion:** 2022-09-08
- **Final completion:** 2022-10-08
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182864, "MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07182864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*